首页> 美国卫生研究院文献>Allergy Asthma and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology >Reproducibility of serum IgE Ara h2 skin prick testing and fraction of exhaled nitric oxide for predicting clinical peanut allergy in children
【2h】

Reproducibility of serum IgE Ara h2 skin prick testing and fraction of exhaled nitric oxide for predicting clinical peanut allergy in children

机译:血清IgEAra h2皮肤点刺试验和呼出气一氧化氮分数的可再现性可预测儿童临床花生过敏

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAra h2 sIgE serum levels improve the diagnostic accuracy for predicting peanut allergy, but the use of Ara h2 purified protein as a skin prick test (SPT), has not been substantially evaluated. The fraction of exhaled nitric oxide (FeNO) shows promise as a novel biomarker of peanut allergy. Reproducibility of these measures has not been determined. The aim was to assess the accuracy and reproducibility (over a time-period of at least 12 months) of SPT to Ara h2 in comparison with four predictors of clinical peanut allergy (Peanut SPT, Ara h2 specific Immunoglobulin E (sIgE), Peanut sIgE and FeNO).
机译:背景Ara h2 sIgE血清水平提高了预测花生过敏的诊断准确性,但是尚未对Ara h2纯化蛋白作为皮肤点刺试验(SPT)的用途进行评估。呼出的一氧化氮(FeNO)的一部分显示出有望作为花生过敏的新生物标记。这些措施的可重复性尚未确定。目的是评估SPT对Ara h2的准确性和可重复性(在至少12个月的时间段内),与临床花生过敏的四种预测因子(花生SPT,Ara h2特异性免疫球蛋白E(sIgE),花生sIgE)进行比较和FeNO)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号